MULTIPLE DATES AND CITES; WEB-BASED OPTIONS ALSO AVAILABLE

OVERVIEW

This seminar series will provide updates on the diagnosis and treatment of the dominant forms of viral hepatitis and explore the latest data on advancing liver PBC, Steatotic Liver Disease and other hepatic conditions.

Faculty experts will deliver state-of-the-art material utilizing a curriculum that features lectures, case analysis, current clinical trial outcomes and progress reports on promising prevention approaches and emerging therapies.

Available in two formats, the content may be explored as both a live, face-to-face seminar or a web-based, self-paced Enduring Material. It is even possible to combine the two modalities. Either way, the goal of this CME activity is to limit future cases and improve the outcomes of those already infected.

PROGRAM HIGHLIGHTS

The seminar topics are presented in live presentations and supplemented by multi-media pre and post-course assignments.
This allows us to make the most of our time together for group discussion, case analysis and patient management approaches.

• HCV diagnosis and treatment updates
• Epidemiology of Hepatitis B and the best anti-viral therapies
• The growing incidence of Delta Hepatitis and its relationship to HBV
• Clinical cases to explore End-stage Liver Disease and transplant options
• New and emerging therapies showing promise for the treatment of Hepatocellular Carcinoma
• Alcohol-associated liver disease
• Diagnosing and treating Hepatorenal Syndrome, Hepatic Encephalopathy, and Thrombocytopenia
• The explosion in Fatty Liver Disease: A dangerous step on the pathway toward Cirrhosis and HCC
• Promising clinical trial data on MASLD and MASH treatment
• Caring for liver patients in special populations and circumstances

ACCREDITATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and SC Liver Research Consortium. The University of Louisville School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Physicians (MD/DO) - The University of Louisville School of Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

FUTURE EVENTS

April 27, 2024 - Miami, FL

May 4, 2024 - Seattle, WA

September 21, 2024 - Cincinnati, OH

October 5, 2024 - Pasadena, CA